Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain

NCT: NCT06185816 · RECRUITING

NCT IDNCT06185816
StatusRECRUITING
Start Date2024-11-01
Completion2029-01-01

Brief Summary

The purpose of this study is to examine non-invasive pulsed radiofrequency (NIPRF) and the effect it has on chronic neuropathic pain. Chronic neuropathic pain after peripheral nerve injury most often occurs in the context of post-traumatic or post-surgical pain. It is often treated with nerve blocks, prescription medication, physical therapy, neuromodulation, and surgery. The study team will be examining the efficacy of NIPRF and determining if it would be an appropriate treatment for chronic neuropathic pain after peripheral nerve injury.The Stimpod used in the present study is FDA approved and will be used for on label purposes.

Frequently Asked Questions

What is Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain?

Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain is a clinical trial registered under NCT06185816. Current status: RECRUITING.

What is the status of NCT06185816?

The current status of NCT06185816 (Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain) is: RECRUITING.

When did Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain start?

Non-Invasive Pulsed Radiofrequency for the Treatment of Neuropathic Pain started on 2024-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.